Medical Products, Technologies; Policy/Strategy/DRA; Intellectual Property Rights (TRIPS) and access to medicines
Narrative description of project:
This assignment is part of the Health Advisory Services – HAS project (EUR 1.999.715,00, 10/2014-10/2017, managed by hera consortium). Its identification number within the HAS is HAS 011.
The HAS provides technical support to the European Commission (DEVCO/HQ) and the EU Delegations for a period of three years. DG DEVCO contracted the HAS to support the implementation of its health aid policies and programmes; strengthen the capacity of EU Delegations and DEVCO/HQ; and tackle other issues for which in-house thematic capacity is lacking or insufficient.
DEVCO/HQ had questions about Technology Transfer on production of MDR-TB medicines, specifically whether the Eli Lilly initiative (as published in a White Paper) had been the “right” thing to do. Any comments on the white paper? Should other producers follow a similar path for other products needed in MDR-TB? Or have they done already so? Or even better?
Evaluation finale du projet d'appui à la formation continue des agents de santé oeuvrant dans les districts et régions sanitaires au Niger (NER0802411)
Total Market Analysis (Baseline and Endline) of Sexual Commodities (Condoms, sexual lubricants and other contraceptive products) in Suriname and Jamaica: free/generic, socially marketed and commercial brands